These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22044000)

  • 1. The sequence specificity of the anti-tumour drug, cisplatin, in telomeric DNA sequences compared with consecutive guanine DNA sequences.
    Murray V; Kandasamy N
    Anticancer Agents Med Chem; 2012 Mar; 12(3):177-81. PubMed ID: 22044000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of cisplatin with a human telomeric DNA sequence containing seventeen tandem repeats.
    Nguyen HT; Galea AM; Murray V
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1041-5. PubMed ID: 23302441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequence selectivity of DNA-targeted 9-aminoacridine cisplatin analogues in a telomere-containing DNA sequence.
    Paul M; Murray V
    J Biol Inorg Chem; 2011 Jun; 16(5):735-43. PubMed ID: 21465324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chromatin structure on cisplatin damage in intact human cells.
    Davies NP; Hardman LC; Murray V
    Nucleic Acids Res; 2000 Aug; 28(15):2954-8. PubMed ID: 10908359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an automated capillary DNA sequencer to investigate the interaction of cisplatin with telomeric DNA sequences.
    Paul M; Murray V
    Biomed Chromatogr; 2012 Mar; 26(3):350-4. PubMed ID: 21678458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes.
    Johnson BW; Murray V; Temple MD
    BMC Cancer; 2016 May; 16():333. PubMed ID: 27225032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GG sequence of DNA and the human telomeric sequence react with cis-diammine-diaquaplatinum at comparable rates.
    Ourliac Garnier I; Bombard S
    J Inorg Biochem; 2007 Mar; 101(3):514-24. PubMed ID: 17224184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
    Burstyn JN; Heiger-Bernays WJ; Cohen SM; Lippard SJ
    Nucleic Acids Res; 2000 Nov; 28(21):4237-43. PubMed ID: 11058123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an automated sequencer to determine the sequence specificity of DNA damage.
    Hardman LC; Murray V
    Biochem Mol Biol Int; 1997 Jun; 42(2):349-59. PubMed ID: 9238534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomeric DNA sequences are a major target for the antitumour drug bleomycin.
    Nguyen TV; Murray V
    J Biol Inorg Chem; 2012 Jan; 17(1):1-9. PubMed ID: 21761251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin intrastrand adducts sensitize DNA to base damage by hydrated electrons.
    Behmand B; Wagner JR; Sanche L; Hunting DJ
    J Phys Chem B; 2014 May; 118(18):4803-8. PubMed ID: 24779712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactions of novel mononuclear platinum-based complexes with DNA.
    Johnson BW; Burgess MW; Murray V; Aldrich-Wright JR; Temple MD
    BMC Cancer; 2018 Dec; 18(1):1284. PubMed ID: 30577821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-cell apoptosis after cisplatin treatment is not telomere dependent.
    Jeyapalan JC; Saretzki G; Leake A; Tilby MJ; von Zglinicki T
    Int J Cancer; 2006 Jun; 118(11):2727-34. PubMed ID: 16381006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GA and AG sequences of DNA react with cisplatin at comparable rates.
    Monjardet-Bas V; Bombard S; Chottard JC; Kozelka J
    Chemistry; 2003 Oct; 9(19):4739-45. PubMed ID: 14566881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA.
    Temple MD; McFadyen WD; Holmes RJ; Denny WA; Murray V
    Biochemistry; 2000 May; 39(18):5593-9. PubMed ID: 10820033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin.
    Scheeff ED; Briggs JM; Howell SB
    Mol Pharmacol; 1999 Sep; 56(3):633-43. PubMed ID: 10462551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the sequence specificity of cis-diamminedichloroplatinum (II) damage in guanine- and 7-deazaguanine-containing DNA.
    Cairns MJ; Murray V
    Biochim Biophys Acta; 1994 Aug; 1218(3):315-21. PubMed ID: 8049257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare example of three abundant conformers in one retro model of the cisplatin-DNA d(GpG) intrastrand cross link. Unambiguous evidence that guanine O6 to carrier amine ligand hydrogen bonding is not important. possible effect of the Lippard base pair step adjacent to the lesion on carrier ligand hydrogen bonding in DNA adducts.
    Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
    J Am Chem Soc; 2001 Sep; 123(38):9345-55. PubMed ID: 11562217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells.
    Grimaldi KA; McAdam SR; Souhami RL; Hartley JA
    Nucleic Acids Res; 1994 Jun; 22(12):2311-7. PubMed ID: 8036159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.